Metrics
1 Record Views
- Title
- Abstract CT246: Tagraxofusp plus venetoclax and azacitidine in patients ineligible for intensive chemotherapy with previously untreated CD123+ acute myeloid leukemia: A phase 2 multicenter trial
- Creators
- Naval G. Daver - The University of Texas MD Anderson Cancer CenterNaveen Pemmaraju - The University of Texas MD Anderson Cancer CenterMikkael A. Sekeres - University of MiamiAmir Fathi - Massachusetts General HospitalAndrew A. Lane - Dana-Farber Cancer InstituteAnna Compagnoni - Menarini GroupIra GuptaAlessandra TosoliniJessica GarzonHagop M. Kantarjian - The University of Texas MD Anderson Cancer Center
- Publication Details
- Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT246-CT246
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032662039302976